OPEN LABEL SINGLE CENTRIC CLINICAL EXPLORATORY OF EFFICACY STUDY ON ASPAROSE CAPSULE, AN AYURVEDIC PROPRIETARY FORMULATION

Introduction: Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, often manifesting as irregular menstrual cycles, abnormal bleeding, and menstrual cramps. Ayurvedic medicine has been widely used for managing such conditions. This study aims to clinically validate the efficacy of the proprietary Ayurvedic Medicine, ASPAROSE Capsule, in alleviating the symptoms associated with PCOS. The primary objective of this Phase-II-A, single-center, open-label, therapeutic exploratory clinical trial was to evaluate the effectiveness of ASPAROSE Capsule in reducing PCOS-related symptoms, such as irregular menstrual cycles, abnormal bleeding disorders, vaginal pain, and menstrual cramps. Methods: A total of20 female patients aged 21-40 years with clinically diagnosed PCOS symptoms were enrolled in the study. Participants were administered 1-2 ASPAROSE Capsules twice daily with lukewarm water for 30 days. Baseline and post-treatment evaluations were conducted using clinical and laboratory assessments. Ethical approval was obtained, and patient consent was secured before study participation. Results: At the end of the 30-day trial period: 70% (14 patients) experienced significant improvement in symptoms. 10% (2 patients) showed moderate improvement. 10% (2 patients) had mild improvement. 10% (2 patients) exhibited no significant improvement. Laboratory investigations supported these findings, demonstrating improved hematological parameters posttreatment. No severe adverse effects were reported, indicating the safety of the medication. Conclusion: ASPAROSE CAPSULE was found to be highly effective in managing PCOS-related menstrual irregularities, abnormal bleeding, and associated pain. The study suggests that this proprietary Ayurvedic formulation may serve as a potential therapeutic option for PCOS management. Further large-scale studies are recommended to confirm these findings.

Authors

Publication Details

Journal
International Journal of Medical and Exercise Science
Published
2025-01-01
DOI
https://doi.org/10.36678/ijmaes.2025.v10i01.001
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OPEN LABEL SINGLE CENTRIC CLINICAL EXPLORATORY OF EFFICACY STUDY ON ASPAROSE CAPSULE, AN AYURVEDIC PROPRIETARY FORMULATION

S. Sridhar, P. Karthikeyan, Saddam Suman, B. Devendran et al.
International Journal of Medical and Exercise Science
Phytochemicals and Medicinal Plants
article

OPEN LABEL SINGLE CENTRIC CLINICAL EXPLORATORY OF EFFICACY STUDY ON ASPAROSE CAPSULE, AN AYURVEDIC PROPRIETARY FORMULATION

S. Sridhar, P. Karthikeyan, Saddam Suman, B. Devendran, S. Moulishankar, G. Raaja, G.S. Aathithiah, M. Vetriselvan, Joemon, R. Pachiyappan
article en

Abstract

Introduction: Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, often manifesting as irregular menstrual cycles, abnormal bleeding, and menstrual cramps. Ayurvedic medicine has been widely used for managing such conditions. This study aims to clinically validate the efficacy of the proprietary Ayurvedic Medicine, ASPAROSE Capsule, in alleviating the symptoms associated with PCOS. The primary objective of this Phase-II-A, single-center, open-label, therapeutic exploratory clinical trial was to evaluate the effectiveness of ASPAROSE Capsule in reducing PCOS-related symptoms, such as irregular menstrual cycles, abnormal bleeding disorders, vaginal pain, and menstrual cramps. Methods: A total of20 female patients aged 21-40 years with clinically diagnosed PCOS symptoms were enrolled in the study. Participants were administered 1-2 ASPAROSE Capsules twice daily with lukewarm water for 30 days. Baseline and post-treatment evaluations were conducted using clinical and laboratory assessments. Ethical approval was obtained, and patient consent was secured before study participation. Results: At the end of the 30-day trial period: 70% (14 patients) experienced significant improvement in symptoms. 10% (2 patients) showed moderate improvement. 10% (2 patients) had mild improvement. 10% (2 patients) exhibited no significant improvement. Laboratory investigations supported these findings, demonstrating improved hematological parameters posttreatment. No severe adverse effects were reported, indicating the safety of the medication. Conclusion: ASPAROSE CAPSULE was found to be highly effective in managing PCOS-related menstrual irregularities, abnormal bleeding, and associated pain. The study suggests that this proprietary Ayurvedic formulation may serve as a potential therapeutic option for PCOS management. Further large-scale studies are recommended to confirm these findings.

International Journal of Medical and Exercise ScienceVol. 11(01)
Openalex Percentile: Top 92%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.